NGM Biopharmaceuticals In... (NGM)
NGM Biopharmaceuticals Max Pain By Strike
NGM trades at $1.54, 95.6% below the near-term max pain of $35 expiring Dec 19, 2025 (124 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($2-$990), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
NGM Biopharmaceuticals Max Pain By Expiry
Max pain for NGM shows a downward trend from 990 to 2, indicating bearish sentiment or hedging activity. The 289% spread signals divergent expectations across timeframes. Most levels above 1.54 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Dec 19, 2025 | 35 | 33.46 (2172.73%) |
Jan 16, 2026 | 2 | 0.46 (29.87%) |
Dec 18, 2026 | 990 | 988.46 (64185.71%) |